Penn team shines a light on blood disorder

Investigators at the Perelman School of Medicine at the University of Pennsylvania. say they have reached some new insights into the structure of a protein complex that is a root cause of a clotting disorder (heparin-induced thrombocytopenia) that strikes patients who receive the anti-clotting drug heparin. Their work was published in Nature Communications. Release

Sponsored By Paraza Pharma

Choosing the Right Pre-Clinical Collaborative Research Organization (CRO)

Learn about the key factors that are essential to creating a collaborative and productive working relationship to advance pre-clinical drug discovery programs.